You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 24, 2024

Etidronate disodium - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for etidronate disodium and what is the scope of freedom to operate?

Etidronate disodium is the generic ingredient in two branded drugs marketed by Mgi Pharma Inc, Apil, and Norvium Bioscience, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for etidronate disodium.

Drug Prices for etidronate disodium

See drug prices for etidronate disodium

Recent Clinical Trials for etidronate disodium

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
UMC UtrechtPhase 2
Netherlands Brain FoundationPhase 2

See all etidronate disodium clinical trials

US Patents and Regulatory Information for etidronate disodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mgi Pharma Inc DIDRONEL etidronate disodium INJECTABLE;INJECTION 019545-001 Apr 20, 1987 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Norvium Bioscience ETIDRONATE DISODIUM etidronate disodium TABLET;ORAL 075800-002 Jan 24, 2003 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Apil DIDRONEL etidronate disodium TABLET;ORAL 017831-002 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Norvium Bioscience ETIDRONATE DISODIUM etidronate disodium TABLET;ORAL 075800-001 Jan 24, 2003 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Apil DIDRONEL etidronate disodium TABLET;ORAL 017831-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for etidronate disodium

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Apil DIDRONEL etidronate disodium TABLET;ORAL 017831-002 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
Apil DIDRONEL etidronate disodium TABLET;ORAL 017831-002 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
Mgi Pharma Inc DIDRONEL etidronate disodium INJECTABLE;INJECTION 019545-001 Apr 20, 1987 ⤷  Sign Up ⤷  Sign Up
Mgi Pharma Inc DIDRONEL etidronate disodium INJECTABLE;INJECTION 019545-001 Apr 20, 1987 ⤷  Sign Up ⤷  Sign Up
Apil DIDRONEL etidronate disodium TABLET;ORAL 017831-001 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
Apil DIDRONEL etidronate disodium TABLET;ORAL 017831-001 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
Apil DIDRONEL etidronate disodium TABLET;ORAL 017831-001 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.